Found this publication (abstract only - no full text) on BTX1503 Phase1 study in a peer-reviewed scientific journal , which goes to show that it did not go unnoticed:
https://www.jidonline.org/article/S0022-202X(18)31300-9/fulltext
also of interest are the results of a recent survey on the perspectives of dermatologists on the uses and potential benefits of cannabinoids as therapies in dermatology, it seems that - when they come - FDA approved drugs based on cannabinoids could prove very popular:
https://www.news-medical.net/news/2...in-recommending-cannabinoids-to-patients.aspx
Ann: Investor Presentation, page-41
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.010(2.82%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.0¢ | 34.5¢ | $424.9K | 1.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 254414 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 53441 | 6 |
View Market Depth
| Last trade - 12.39pm 27/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
